{Reference Type}: Journal Article
{Title}: LITHIUM-INDUCED NEPHROGENIC DIABETES INSIPIDUS RESPONSIVE TO DESMOPRESSIN.
{Author}: Şenocak Taşçi E;Eralp H;Kayataş K;
{Journal}: Acta Endocrinol (Buchar)
{Volume}: 15
{Issue}: 2
{Year}: Apr-Jun 2019
{Factor}: 1.104
{DOI}: 10.4183/aeb.2019.270
{Abstract}: Nephrogenic diabetes insipidus (NDI) is the most common renal side effect seen with lithium therapy. Persisting cases after the cessation of the therapy may be seen when lithium therapy is continued for too long. Although desmopressin treatment is not one of the accepted treatment modalities for NDI, there are few reports using desmopressin treatment in unresponsive cases. Herein, we reported the fourth lithium-induced NDI case in the literature responsive to desmopressin therapy.